| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 648.845 | 769.882 | 749.046 | 807.853 | 890.034 | 715.517 | 760.594 | 932.065 | 1.260.309 | 1.450.455 |
| Total Income - EUR | 652.855 | 788.608 | 762.146 | 813.299 | 895.510 | 753.740 | 854.536 | 952.690 | 1.272.822 | 1.656.770 |
| Total Expenses - EUR | 539.978 | 614.463 | 640.722 | 707.983 | 755.235 | 657.792 | 696.701 | 799.811 | 1.018.040 | 1.367.431 |
| Gross Profit/Loss - EUR | 112.877 | 174.144 | 121.424 | 105.316 | 140.275 | 95.948 | 157.835 | 152.879 | 254.782 | 289.340 |
| Net Profit/Loss - EUR | 94.507 | 149.232 | 100.879 | 97.201 | 133.121 | 91.983 | 151.847 | 144.503 | 223.577 | 254.870 |
| Employees | 31 | 27 | 26 | 26 | 25 | 24 | 25 | 26 | 29 | 26 |
Check the financial reports for the company - Osteopharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 172.506 | 192.827 | 204.086 | 189.852 | 169.840 | 153.422 | 136.482 | 131.156 | 124.950 | 110.478 |
| Current Assets | 231.700 | 225.997 | 231.387 | 349.520 | 311.547 | 267.663 | 316.343 | 408.732 | 562.082 | 710.742 |
| Inventories | 82.162 | 141.554 | 178.690 | 258.761 | 206.096 | 181.416 | 212.226 | 233.432 | 257.479 | 226.414 |
| Receivables | 119.917 | 42.273 | 42.690 | 82.770 | 113.365 | 141.208 | 72.678 | 152.931 | 180.409 | 303.350 |
| Cash | 29.621 | 42.170 | 10.007 | 7.989 | -7.913 | -54.961 | 31.439 | 22.368 | 124.194 | 180.978 |
| Shareholders Funds | 212.210 | 206.584 | 229.077 | 225.283 | 241.785 | 250.011 | 279.224 | 154.560 | 377.457 | 336.570 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 197.257 | 214.214 | 207.657 | 314.715 | 240.288 | 172.638 | 144.396 | 385.883 | 270.174 | 356.714 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 30.001 | 0 | 40.886 | 129.307 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Osteopharm Srl